18449006

Source:http://linkedlifedata.com/resource/pubmed/id/18449006

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006826, umls-concept:C0030705, umls-concept:C0045093, umls-concept:C0205195, umls-concept:C0817096, umls-concept:C0920321, umls-concept:C1527223
pubmed:issue	5
pubmed:dateCreated	2008-5-1
pubmed:abstractText	Nab-paclitaxel has a different toxicity profile than solvent-based paclitaxel including a lower rate of severe neutropenia. This trial was designed to determine the maximum tolerated dose and dose limiting toxicities (DLT) of nab-paclitaxel in combination with gemcitabine.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/M01 RR000046-476475, http://linkedlifedata.com/resource/pubmed/grant/RR00046
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/18449006-10561261, http://linkedlifedata.com/resource/pubmed/commentcorrection/18449006-10561275, http://linkedlifedata.com/resource/pubmed/commentcorrection/18449006-10655437, http://linkedlifedata.com/resource/pubmed/commentcorrection/18449006-10791395, http://linkedlifedata.com/resource/pubmed/commentcorrection/18449006-10997809, http://linkedlifedata.com/resource/pubmed/commentcorrection/18449006-11032599, http://linkedlifedata.com/resource/pubmed/commentcorrection/18449006-11822754, http://linkedlifedata.com/resource/pubmed/commentcorrection/18449006-11870177, http://linkedlifedata.com/resource/pubmed/commentcorrection/18449006-12006516, http://linkedlifedata.com/resource/pubmed/commentcorrection/18449006-12202657, http://linkedlifedata.com/resource/pubmed/commentcorrection/18449006-12351606, http://linkedlifedata.com/resource/pubmed/commentcorrection/18449006-12697880, http://linkedlifedata.com/resource/pubmed/commentcorrection/18449006-14691125, http://linkedlifedata.com/resource/pubmed/commentcorrection/18449006-14731324, http://linkedlifedata.com/resource/pubmed/commentcorrection/18449006-15545667, http://linkedlifedata.com/resource/pubmed/commentcorrection/18449006-16135470, http://linkedlifedata.com/resource/pubmed/commentcorrection/18449006-16172456, http://linkedlifedata.com/resource/pubmed/commentcorrection/18449006-16740598, http://linkedlifedata.com/resource/pubmed/commentcorrection/18449006-17167137, http://linkedlifedata.com/resource/pubmed/commentcorrection/18449006-17285317, http://linkedlifedata.com/resource/pubmed/commentcorrection/18449006-17562230, http://linkedlifedata.com/resource/pubmed/commentcorrection/18449006-18235124
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101274235
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/130-nm albumin-bound paclitaxel, http://linkedlifedata.com/resource/pubmed/chemical/Albumins, http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine, http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel, http://linkedlifedata.com/resource/pubmed/chemical/gemcitabine
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	1556-1380
pubmed:author	pubmed-author:DeesE ClaireEC, pubmed-author:GoldbergRichard MRM, pubmed-author:HayesD NeilDN, pubmed-author:LeeCarrie BCB, pubmed-author:MooreDominic TDT, pubmed-author:SocinskiMark AMA, pubmed-author:StinchcombeThomas ETE
pubmed:issnType	Electronic
pubmed:volume	3
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	521-6
pubmed:dateRevised	2010-9-21
pubmed:meshHeading	pubmed-meshheading:18449006-Adult, pubmed-meshheading:18449006-Aged, pubmed-meshheading:18449006-Albumins, pubmed-meshheading:18449006-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:18449006-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:18449006-Carcinoma, Small Cell, pubmed-meshheading:18449006-Deoxycytidine, pubmed-meshheading:18449006-Esophageal Neoplasms, pubmed-meshheading:18449006-Female, pubmed-meshheading:18449006-Humans, pubmed-meshheading:18449006-Lung Neoplasms, pubmed-meshheading:18449006-Male, pubmed-meshheading:18449006-Middle Aged, pubmed-meshheading:18449006-Nanoparticles, pubmed-meshheading:18449006-Paclitaxel, pubmed-meshheading:18449006-Survival Rate, pubmed-meshheading:18449006-Treatment Outcome
pubmed:year	2008
pubmed:articleTitle	Phase I trial of nanoparticle albumin-bound paclitaxel in combination with gemcitabine in patients with thoracic malignancies.
pubmed:affiliation	Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7305, USA. Thomas_Stinchcombe@med.unc.edu
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Clinical Trial, Phase I, Research Support, N.I.H., Extramural